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Abstract 
As treatment and survival of acute leukemia as well as other types of pediatric 
cancer improve, the number of second malignancies in these treated patients will 
increase. Occurrence of these second malignancies in the head and neck is not 
frequently reported although it is known that radiation treatment, chemotherapy 
and sometimes the primary lesion itself are risk factors for neoplasia. Malignancies 
of the parotid gland in the pediatric population are known to be unusual. We 
discuss a mucoepidermoid carcinoma in a lo-year-old female who 7 years earlier 
had undergone successful treatment of acute lymphoblastic leukemia. 
Introduction 
Parotid tumors in the pediatric age group are unusual [2,31. Among pediatric 
parotid tumors, mucoepidermoid carcinoma is a more common malignant tumor 
than in adults [5], where it comprises 3-10% of parotid masses [l]. Some authors 
have found that mucoepid&moid carcinoma in children represents as much as 
50% of all parotid tumors [2,3]. In a large series of pediatric patients followed after 
treatment for a malignancy, it has been observed that adult-type tumors, such as 
carcinoma, tend to appear earlier [9]. In this report a patient is discussed who 
presented with a mucoepidermoid carcinoma of the parotid gland 7 years after 
treatment of leukemia. 




A lo-year-old female presented with a two-month history of a right parotid mass 
that had been refractory to antibiotic therapy. There was no associated pain, fever, 
erythema, trismus or facial nerve deficit. 
Her past medical history was significant for acute lymphoblastic leukemia 
diagnosed at the age of 3 years. She had received combination chemotherapy 
(vincristine, 6-mercaptopurine, methotrexate, prednisone) for 3.5 years and had 
been in complete remission since initial induction. 
At the time of examination, a soft non-tender 2.5 cm mass was present in the 
parotid area. The VIIth nerve was noted to be completely intact and no other 
cervical masses were observed. 
A CAT scan of the parotid region revealed a zone of increased attenuation in 
the superficial lobe of the right parotid with no evidence of deep lobe or 
parapharyngeal space extension (Fig. 1). 
At the time of parotidectomy, the superficial lobe was noted to contain a 2 X 2 
cm lesion, microscopically confirmed to be low grade mucoepidermoid carcinoma 
Fig. 1. A CAT scan of the parotid gland showed a zone of moderately increased attenuation in the 
lateral aspect of the superficial lobe of the right parotid gland which has poorly defined margins. There 
did not appear to be deep lobe involvement. 
Fig. 2. Histopathologic evaluation of the parotid mass showed this low graae mucoeplctermold 
carcinoma with focal mucin (arrow). Note that the tumor is partially cystic. (mucicarmine stain; 
magnification X 300) 
(Fig. 2). A total parotidectomy was performed. The postoperative course was 
uneventful. All of the branches of the VIIth nerve functioned fully. There has been 
no evidence of recurrence 24 months after surgery. 
Discussion 
The Late Effects Study Group (LESG), which has a large on-going multi-center 
study following children diagnosed with cancer, has found retinoblastoma is the 
most common first tumor in the patients that develop a second malignancy [lO,ll]. 
Other tumors, in decreasing order of frequency include, Hodgkin’s disease, Wilm’s 
tumor, soft tissue sarcomas, brain tumors, neuroblastomas and leukemia. 
Retinoblastoma and Hodgkin’s disease typically make up < 10% of pediatric 
neoplasms but they represent 30% of primary tumors in this situation [ll]. 
Kingston et al. [61, in their discussion of 161 pediatric patients with second 
primary neoplasms, report that central nervous system tumors are the most 
common first tumor (45/161), retinoblastomas are the second (37/161) and 
leukemia and lymphoma as a group comprise 33/161. In their study they noted a 
change in pattern of first primaries. Prior to 1970 retinoblastoma and central 
nervous system tumors were most frequently associated with second primary 
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tumors whereas after 1970 leukemia and lymphoma have been the major group. 
This may reflect improvement in survival of leukemia and lymphoma as well as 
exposure to more carcinogenic therapies. 
When considering second primary tumors, osteosarcomas and chondrosarcomas 
are the most common [91. Soft tissue and bone sarcomas compose 30% of the 
second tumors [ill. Bone sarcomas are the most common second primary tumors 
in previously irradiated sites while leukemia is the most common cancer unassoci- 
ated with radiation therapy [lo]. It has also been noted that adult-type tumors, 
such as carcinomas, tend to appear at earlier ages [9]. 
In these patients, as well as in most other settings, radiotherapy is felt to be 
carcinogenic. Kingston et al. 161, in their review of pediatric patients with second 
neoplasms, found that 77 of 125 patients who received radiation had a second 
malignant neoplasm within the radiation field. Sixteen of these 125 patients 
developed leukemia. Overall they felt that they could attribute 93 of the 161 (61%) 
second tumors to radiation. Meadows et al. [lo] noted 208 of their 292 (68%) 
pediatric patients had second malignant neoplasms developing in tissue exposed to 
radiation, with sarcoma being the most common. Hawkins et al. [4] noted a 6-fold 
increase in the risk of second primary tumor with radiation and a 9-fold increase if 
chemotherapy is given in combination with radiation therapy. 
The risk in patients receiving chemotherapy is less. In general the greatest risk 
in patients who received cytotoxic drugs was the development of leukemias and 
lymphomas Ill]. Most larger studies do note an increased risk with cytotoxic drugs 
aIthough not to the same degree as radiotherapy. Kingston et al. [6J noted that of 
50 children who received cytoxic drugs the most common second primary tumor 
was acute non-lymphocytic leukemia. 
Another risk factor in these patients is a genetic abnormality. This is known to 
be true for patients with retinoblastoma and at least partially explains why these 
patients make up such a large portion of the second maligancy group [lo]. The role 
of heredity in the other first neoplasms is less certain. 
The risk of a neoplasm in a child already treated for cancer is significantly 
higher than for age-matched controls. From 3 to 12% of these patients will develop 
a second tumor at least 3-5 years (depending on the methods in the particular 
study) after treatment of the initial cancer [4,7,10,11,131. This represents a risk of 
6-20 X that of the control population. 
The latency period between tumors varied from 5 months to 34 years in the 
experience of Meadows et al. [lo]. When the tumor appeared within a radiation 
field the median latency was 10 years and when the second tumor was unassoci- 
ated with radiation the median latency was 5 years. In our patient who did not 
receive radiation treatment the latency was 6 years. 
In 1981, Mosijczuk and Ruymann [12] reviewed the literature and found 33 
malignancies in patients who had been previously diagnosed with acute lym- 
phoblastic leukemia. Nine of thesecondary cancers were solid malignancies but 
none of the tumors were of the head and neck region. 
In 1989, Loy et al. [81 reported two patients with acute leukemia who subse- 
quently developed mucoepidermoid carcinoma of the parotid gland. Their first 
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patient was a 15year-old female with acute lymphoblastic Ieukemia who had been 
treated with combination chemotherapy as well as cranial radiation. Six years after 
diagnosis, and 3 years after completion of chemotherapy, a right parotid mucoepi- 
dermoid carcinoma was diagnosed. Their second patient was a lo-year-old who 
had received combination chemotherapy and cranial radiation after diagnosis of 
acute myelomonocytic leukemia at age one year. This patient was treated with 
chemotherapy again at age 3 years for a relapse. 
The only other reference to a parotid neoplasm occurring after treatment of a 
separate neoplasm was by Kingston et al. [6]. In one of their cases a carcinoma of 
the parotid gland occurred after treatment of leukemia but neither the type of 
leukemia nor the parotid cancer were identified. 
The patient we presented is a lo-year-old female who had been diagnosed with 
acute lymphoblastic leukemia at the age of 3 years. At that time she had been 
treated with a 3-year course of combined chemotherapy with subsequent complete 
remission. 
Tefft et al. [13] made the important statement concerning children that have 
been successfully treated for a primary malignancy-any child with a diagnosis of 
cancer, who survives the disease, must at no time be lost to follow-up examination 
at frequent intervals. 
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